Company*
(Country;
Symbol)

Company*
(Country;
Symbol)

Product

Terms/Details (Date)


Albany Molecular Research Inc.
(AMRI)

Seattle Genetics
Inc.
(SGEN)

Albany Molecular will manufacture the drug-
linker system used in Seattle Genetics' SGN-35 product

Clinical trials of the antibody-drug conjugate are expected to begin in 2006; the deal also provides licensees of Seattle Genetics' ADC technology to work directly with Albany Molecular to obtain drug-linkers for their own trials (5/5)

BioReliance
Corp.
(subsidiary
of Invitrogen Corp.; IVGN)

Acambis plc
(UK; ACAM)

Acambis acquired a U.S.- based fill/finish facility, where it will manufacture vaccines

BioReliance gets $3M up front and another $4.5M over 12 years; Acambis will assume responsibility for the 12-year lease (5/9)

Capital Genomix
Inc.*

SpectruMedix
LLC*

Worldwide deal to market and sell the GeneSystem-320 for capillary electrophoresis-based applications.

The companies intend to launch the product in 3Q:05; terms were not disclosed (5/4)

Cobra Bio- manufacturing
plc
(UK;
LSE:CBF)

Synco
BioPartners*

(the Netherlands)

Collaboration to manufacture plasmid DNA for Phase III trials and commercial supply

Synco licensed rights related to the pDNA manufacturing process; they also will work together on marketing of their pDNA manufacturing services (5/4)

Gene Bridges
GmbH*

(Germany)

Covalys
Biosciences
AG*
(Switzerland)

Deal to develop DNA engineering kits to generate SNAP-tag fusion proteins

The work is based on Gene Bridges' Red/ET recombination technology; the cloning kits are expected to be on the market in 3Q:05 (6/14)

Inte:Ligand
GmbH*
(Austria)

Molecular
Networks*
(Germany)

Deal to integrate
Molecular Networks' Corina technology into Inte:Ligand's Ilib Diverse platform

Ilib Diverse is a virtual compound library- generation platform; they also plan to share complementary technologies in the future (4/26)

Invitrogen
Corp.
(IVGN)

Applied
Biosystems

Group
(NYSE:
ABI)

Co-marketing deal to sell a combined collection of labeling technologies

The products include ABI's iTRAQ and ICAT reagents and Invitrogen's SILAC technology; ABI also will provide software support for SILAC; terms were not disclosed (6/6)

Lorantis
Ltd.*
(UK)

Althea
Technologies

Inc.*

Althea will manufacture the protein component of Lorantis' HepVax, a hepatitis B therapeutic vaccine

Althea will provide a range of services under the contract as the product advances toward clinical evaluation; terms were not disclosed (4/27)

Luminex Corp.
(LMNX)

EraGen
Biosciences

Inc.*

The companies entered an expanded licensing and distribution agreement

EraGen got rights to sell Luminex 100 Systems and kits that include nonstandard nucleic acid bases, proprietary to EraGen, designed for certain in vitro clinical diagnostic purposes (4/26)

Primus Pharmaceuticals
Inc.*

CollaGenex Pharmaceuticals
Inc.
(CGPI)

Deal under which CollaGenex will promote Alcortin and Novacort to dermatologists in the U.S.

Alcotrin is a topical antifungal steroid combination; Novacort is a topical steroid and anesthetic; terms of the deal were not disclosed (6/8)

Procognia
Ltd.*
(UK)

Qiagen NV
(the Netherlands;
QGEN)

Qiagen got exclusive rights to market Procognia's "on-chip" protein glycoanalysis technology

The products will be combined with Qiagen's QProteome product line; terms of the deal were not disclosed (5/16)

Protein
Sciences
Corp.*

ViRexx Medical
Corp.
(Canada; TSE:VIR)

Deal under which PSC will manufacture ViRexx's lead Chimigen vaccine, HepaVaxx B

Phase I trials of the hepatitis B vaccine are expected to begin in 3Q:05; terms of the deal were not disclosed (4/28)

Proteos Inc.*

DNAPrint Genomics Inc.
(OTC BB:
DNAP)

Proteos will manufacture DNAP's PT-401 (Super EPO dimer) for preclinical testing

Terms of the deal were not disclosed (5/14)

StemCo
Biomedical
Inc.*

StemCell Technologies* (Canada)

Worldwide deal under which StemCell will distribute StemCo's Aldefluor product

Aldefluor is a kit that enables the identification of stem and progenitor cells; StemCell previously had rights only in the Americas and much of the Asia-Pacific region (6/9)


Notes:

* Private companies are indicated with an asterisk.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

LSE = London Stock Exchange; NYSE = New York Stock Exchange; TSE = Toronto Stock Exchange.